The Chinese University of Hong Kong has announced the launch of a prospective, single-center study focusing on the use of the SHURUI Single-Port Surgical Robot (device model SR-ENS-600) in thoracic surgery. This trial underscores advancements in robotic-assisted surgery aimed at improving procedural outcomes for patients. The study is listed as “Not yet recruiting” as of the publication date, December 1, 2025.
What is the purpose of this study?
This clinical trial aims to evaluate the safety, efficacy, and usability of the SHURUI SR-ENS-600 Endoscopic Surgical System in thoracic surgery. Conducted by the Chinese University of Hong Kong, the study seeks to provide evidence supporting the adoption of single-port robotic-assisted technology for minimally invasive procedures.
Such robotic systems are designed to enhance precision and reduce complications, potentially leading to shorter recovery times for patients. This aligns with ongoing global trends to utilize advanced robotics in specialized surgical fields.
What are the key details?
Sponsor: Chinese University of Hong Kong
Condition: Thoracic Surgery
Interventions: Utilization of the SHURUI Single-Port Endoscopic Surgical System (SR-ENS-600 model).
The study is yet to commence recruitment, offering an opportunity for medical professionals and institutions to engage upon its commencement. Details are available on ClinicalTrials.gov under the identifier NCT07255703.
What are the implications for clinical teams?
If the SHURUI system demonstrates strong performance and safety metrics, it may become a significant tool in clinical thoracic surgical practices. Adoption of robotic systems can lead to:
- Improved surgical precision and consistency.
- Potentially reduced post-operative complications and shorter hospital stays.
- Opportunities for surgeons to expand the scope of minimally invasive techniques.
Clinical and regulatory teams should monitor advancements in this technology to assess its utility and integration potential within their institutions.
FAQ
1. What is the SHURUI SR-ENS-600?
The SR-ENS-600 is a single-port robotic surgical system designed for minimally invasive thoracic procedures.
2. Who is conducting the study?
The Chinese University of Hong Kong is the sponsor of this prospective clinical trial.
3. When will recruitment begin?
The study is not yet recruiting, and specific dates have not been announced.
Conclusion
The SHURUI Single-Port Surgical Robot SR-ENS-600 trial marks an important step in the evolution of robotic-assisted surgery for thoracic conditions. Clinical, quality, and regulatory professionals should stay informed about this study’s findings to understand how it may reshape minimally invasive surgical practices globally.
Disclaimer
This article is for informational purposes only and does not constitute legal, clinical, or regulatory advice. Always consult appropriate sources before making decisions.
Announcement link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07255703?term=medical+device